289 related articles for article (PubMed ID: 24118160)
21. Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.
Groheux D; Hatt M; Hindié E; Giacchetti S; de Cremoux P; Lehmann-Che J; Martineau A; Marty M; Cuvier C; Cheze-Le Rest C; de Roquancourt A; Visvikis D; Espié M
Cancer; 2013 Jun; 119(11):1960-8. PubMed ID: 23504954
[TBL] [Abstract][Full Text] [Related]
22. Positron emission tomography in gynecological malignancies.
Kumar R; Chauhan A; Jana S; Dadparvar S
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1033-44. PubMed ID: 16831075
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826
[TBL] [Abstract][Full Text] [Related]
24. Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.
Kitajima K; Murakami K; Yamasaki E; Hagiwara S; Fukasawa I; Inaba N; Kaji Y; Sugimura K
Ann Nucl Med; 2008 Feb; 22(2):103-9. PubMed ID: 18311534
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
26. Endometrial stromal sarcoma metastatic to the lung: a detailed analysis of 16 patients.
Aubry MC; Myers JL; Colby TV; Leslie KO; Tazelaar HD
Am J Surg Pathol; 2002 Apr; 26(4):440-9. PubMed ID: 11914621
[TBL] [Abstract][Full Text] [Related]
27. 18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
Zhao Z; Yoshida Y; Kurokawa T; Kiyono Y; Mori T; Okazawa H
J Nucl Med; 2013 Apr; 54(4):499-506. PubMed ID: 23471314
[TBL] [Abstract][Full Text] [Related]
28. Low-grade endometrial stromal sarcoma with sex cord-like differentiation metastatic to the thoracic spines.
Al-Salam S; El-Terifi H; Ghazal-Aswad S
APMIS; 2006 Sep; 114(9):651-5. PubMed ID: 16948819
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma.
Cade TJ; Quinn MA; Rome RM; Polyakov A
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):453-6. PubMed ID: 25287561
[TBL] [Abstract][Full Text] [Related]
30. Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease.
Ryu SY; Kim K; Kim Y; Park SI; Kim BJ; Kim MH; Choi SC; Lee ED; Lee KH; Kim BI
J Korean Med Sci; 2010 Jul; 25(7):1029-33. PubMed ID: 20592894
[TBL] [Abstract][Full Text] [Related]
31. Correlation between expression of biological markers and [F]fluorodeoxyglucose uptake in endometrial cancer.
Jo MS; Choi OH; Suh DS; Yun MS; Kim SJ; Kim GH; Jeon HN
Oncol Res Treat; 2014; 37(1-2):30-4. PubMed ID: 24613906
[TBL] [Abstract][Full Text] [Related]
32. Cytologic diagnosis of low grade endometrial stromal sarcoma by staining for estrogen and progesterone receptors.
Reich O; Pickel H; Regauer S
Acta Cytol; 2002; 46(4):790-2. PubMed ID: 12146057
[No Abstract] [Full Text] [Related]
33. Endometrial Stromal Sarcoma of the Uterus: Magnetic Resonance Imaging Findings Including Apparent Diffusion Coefficient Value and Its Correlation With Ki-67 Expression.
Li HM; Liu J; Qiang JW; Gu WY; Zhang GF; Ma FH
Int J Gynecol Cancer; 2017 Nov; 27(9):1877-1887. PubMed ID: 28906310
[TBL] [Abstract][Full Text] [Related]
34. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases.
Masand RP; Euscher ED; Deavers MT; Malpica A
Am J Surg Pathol; 2013 Nov; 37(11):1635-47. PubMed ID: 24121169
[TBL] [Abstract][Full Text] [Related]
35. Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Lee DW; Chong GO; Lee YH; Hong DG; Cho YL; Jeong SY; Park JY; Lee YS
Int J Gynecol Cancer; 2015 Jun; 25(5):843-9. PubMed ID: 25347093
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
37. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of (18)F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis.
Gwak HS; Youn SM; Chang U; Lee DH; Cheon GJ; Rhee CH; Kim K; Kim HJ
Minim Invasive Neurosurg; 2006 Jun; 49(3):127-34. PubMed ID: 16921451
[TBL] [Abstract][Full Text] [Related]
39. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary metastases of uterine endometrial stromal sarcoma: diffuse micronodular and ground glass opacities: a case report.
Kim GY; Sung CO; Han J; Park JO; Lee KS
J Korean Med Sci; 2004 Dec; 19(6):901-3. PubMed ID: 15608407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
